Development and validation of risk-stratified biopsy decision pathways incorporating MRI and PSA-derived indicators

Development and validation of risk-stratified biopsy decision pathways incorporating MRI and PSA-derived indicators

Objectives Develop risk-adapted conditional biopsy pathways utilizing MRI in combination with prostate-specific antigen (PSA) density (PSAD) and the ratio of free to total PSA (f/tPSA), respectively, to enhance the detection of clinically significant prostate cancer (csPCa) while minimizing ‘negativ...

Full description

Saved in:
Bibliographic Details
Main Authors: Pengfei Jin, Ximing Wang, Zhenwei Ding, Liqin Yang, Chenyang Xu, Xu Wang, Fawei Huang
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Annals of Medicine
Subjects:
Prostate cancer
magnetic resonance imaging
prostate-specific antigen density
the ratio of free to total prostate-specific antigen
biopsy indicator
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2024.2446695
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/07853890.2024.2446695

Similar Items